王振常治疗肝硬化的经验浅析
Brief Analysis of WANG Zhenchang's Experience in Treatment of Cirrhosis
DOI:10.13192/j.issn.1000-1719.2021.08.010
扫 描 看 全 文
1.广西国际壮医医院,广西 南宁 530201
2.广西高发传染病中西医结合转化医学重点实验室,广西 南宁 530299
3.广西中医药大学第一附属医院,广西 南宁 530023
扫 描 看 全 文
蒋俊娥, 王振常, 陈丹丹, 等. 王振常治疗肝硬化的经验浅析[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2021.08.010
JIANG Jun'e, WANG Zhenchang, CHEN Dandan, et al. Brief Analysis of WANG Zhenchang's Experience in Treatment of Cirrhosis[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2021.08.010
蒋俊娥, 王振常, 陈丹丹, 等. 王振常治疗肝硬化的经验浅析[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2021.08.010 DOI:
JIANG Jun'e, WANG Zhenchang, CHEN Dandan, et al. Brief Analysis of WANG Zhenchang's Experience in Treatment of Cirrhosis[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2021.08.010 DOI:
目的,2,浅析王振常教授临床治疗肝硬化的经验。,方法,2,分别从病因病机、治法治则等方面探讨王振常教授治疗肝硬化的临床经验,归纳总结柔肝化纤颗粒治疗肝硬化用药规律,并列举典型病例1则。,结果,2,王振常教授认为虚、湿、瘀贯穿于肝硬化病程的始末,三者互相并存,互为因果。肝硬化病因病机主要是肝肾阴虚,肝体失养,肝失疏泄,湿、瘀等内生或乘虚外袭,与虚损之肝体搏结为患。治疗当以滋补肝肾、散瘀化湿为原则。王教授治疗肝病遵从“见肝之病知肝传脾,当先实脾”“肝肾同源”理念,在此基础上创立了治疗肝硬化临床验方柔肝化纤颗粒,并证实在柔肝化纤颗粒基础上辨证加减治疗肝硬化可获得良好临床疗效。,结论,2,王振常教授通过辨证施治,根据湿、瘀、虚等不同病机应用柔肝化纤颗粒为主方治疗肝硬化疗效确切,能够有效控制肝硬化患者的病情发展,值得借鉴与学习。
Objective,2,To analyze Professor WANG Zhenchang's clinical experience on treating liver cirrhosis.,Methods,2,Professor WANG Zhenchang's clinical experience in the treatment of liver cirrhosis was discussed from the aspects of etiology and pathogenesis, rule of medication, etc. The medication rule of Rougan Huaxian Granules (柔肝化纤颗粒) in the treatment of liver cirrhosis was summarized, and a typical case was listed.,Results,2,Professor WANG Zhenchang believed that deficiency, dampness and blood stasis ran through the whole course of liver cirrhosis, and the three coexisted and caused each other. The etiology of liver cirrhosis was mainly due to liver and kidney Yin deficiency, loss of liver support, liver failing to disperse and drain, endogenous or exogenous invasion of dampness and blood stasis, which was associated with liver due to deficiency. Treatment should be based on the principle of nourishing liver and kidney, dispelling blood stasis and eliminating dampness. Professor WANG's treatment of liver diseases follows the concepts that "liver disease would transform into spleen, and spleen should be strengthened first" and "liver and kidney are homologous" . On this basis, Professor WANG created Rougan Huaxian Granules, a clinical prescription for the treatment of liver cirrhosis, and confirmed that a good clinical effect can be obtained by modified Rougan Huaxian Granules according to syndrome differentiation.,Conclusion,2,Based on differentiation of symptoms and signs and according to different pathogenesis such as dampness, blood stasis and deficiency, Professor WANG Zhenchang uses Rougan Huaxian Granules as the main prescription for liver cirrhosis which can effectively control the disease development of liver cirrhosis patients, worthy of reference and study.
肝硬化名医经验王振常
liver cirrhosisexperience of famous doctorWANG Zhenchang
孙润菲, 陈曦, 孙明瑜.清代以来名中医治疗肝硬化学术思想撷菁[J].辽宁中医药大学学报, 2017, 19(5): 99-102.
黄琳, 崔应麟, 朱广领.石冠卿教授“燮理阴阳法”治疗肝硬化经验[J].时珍国医国药, 2019, 30(2): 478-479.
温智稀, 黄晶晶, 王振常, 等.中医药干预间充质干细胞治疗肝硬化的进展[J].辽宁中医杂志, 2017, 44(6): 1331-1333.
姚思梦, 潘静琳, 张长荣, 等.刘凤斌采用补气健脾祛瘀利水法治疗肝硬化难治性腹水经验[J].广州中医药大学学报, 2020, 37(2): 358-361.
孙小慧, 李志远, 赵燕, 等.从风、痰、瘀论治乳腺癌脑转移[J].中医药导报, 2019, 25(23): 70-73.
熊明鹏, 王振常, 黄晶晶.柔肝化纤颗粒联合粒细胞集落刺激因子治疗慢性乙型肝炎肝衰竭的疗效观察[J].辽宁中医杂志, 2017, 44(9): 1908-1910.
黄晶晶, 毛德文, 王振常, 等.柔肝化纤方联合自体骨髓干细胞移植对肝衰竭患者外周血中T细胞亚群和NK、NKT细胞影响[J].辽宁中医药大学学报, 2018, 20(11): 108-111.
韦冬珏, 叶冬梅, 张凤英, 等.中药复方柔肝化纤颗粒干预肝纤维化模型大鼠肝脏微循环障碍的变化[J].中国组织工程研究, 2019, 23(3): 453-457.
黄晶晶, 黄鸿娜, 潘哲, 等.柔肝化纤方辨证治疗乙肝肝硬化失代偿期的临床研究[J].中医药导报, 2015, 21(17): 8-10.
黄鸿娜, 黄晶晶, 王振常, 等.恩替卡韦联合柔肝化纤颗粒治疗慢性乙型肝炎肝衰竭的临床观察[J].现代中西医结合杂志, 2014, 23(33): 3700-3703.
黄晶晶, 黄鸿娜, 王振常, 等.柔肝化纤方联合腹水超滤浓缩回输术治疗肝硬化腹水40例临床观察[J].河北中医, 2014, 36(10): 1492-1495.
莫志华, 王振常, 黄晶晶, 等.柔肝化纤颗粒治疗食管胃底静脉曲张破裂出血及腹水的临床研究[J].河南中医, 2014, 34(10): 1917-1919.
黄鸿娜, 黄晶晶, 王振常, 等.柔肝化纤颗粒治疗肝硬化脾功能亢进症的临床观察[J].西部中医药, 2014, 27(9): 111-113.
覃伟华, 王振常, 黄晶晶, 等.柔肝化纤颗粒对慢性肝病患者血清氨基酸谱异常的作用[J].中外医疗, 2014, 33(18): 127-129.
覃伟华, 王振常, 黄晶晶, 等.柔肝化纤颗粒联合阿德福韦酯治疗慢性乙型肝炎纤维化的临床效果及安全性评价[J].检验医学与临床, 2014, 11(11): 1532-1534.
吕艳杭, 吴姗姗, 王振常.阿德福韦酯联合柔肝化纤颗粒治疗慢性乙型肝炎肝硬化临床效果[J].中国医药导报, 2019, 16(32): 107-110.
吕艳杭, 吴姗姗, 王振常, 等.柔肝化纤颗粒联合骨髓间充质干细胞移植治疗乙肝肝硬化的临床观察[J].中医药导报, 2019, 25(20): 115-118.
吴姗姗, 吕艳杭, 王振常, 等.壮方柔肝化纤颗粒治疗肝肾阴虚型乙肝肝硬化腹水的效果[J].中国医药导报, 2020, 17(1): 122-125.
莫志华, 王振常, 黄晶晶, 等.柔肝化纤颗粒治疗食管胃底静脉曲张破裂出血及腹水的临床研究[J].河南中医, 2014, 34(10): 1917-1919.
黄鸿娜, 黄晶晶, 潘哲, 等.柔肝化纤方联合西药治疗肝硬化伴糖尿病肝肾阴虚型56例[J].环球中医药, 2014, 7(9): 709-712.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构